Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. senior Avg
|
New words:
accused, acid, advice, Alto, art, BCPIA, bound, climate, closure, cloud, Coalition, correspondingly, corroborated, curb, decree, DNA, DOC, DOJ, emission, excused, expert, explore, graft, host, identification, immunotherapy, Imputation, inappropriate, inconsistent, input, interchangeable, IPR, landlord, lost, Markman, misrepresentation, molecular, moot, necessity, newly, occupy, ODAC, OSA, owner, Palo, PBL, pertinent, Political, porcine, Porton, pre, prejudice, prepaid, principle, profile, proper, propriety, quick, rapid, regime, relapsed, removed, renamed, Rent, resume, sector, serum, shaped, signal, software, space, steroid, streamlined, stringent, sublease, sweeping, tenant, understood, valproate, valproic, valuable, verify, vial, water, welfare, workplace, write
Removed:
abandonment, acceleration, Accredo, adjunctive, administered, administering, aggregated, al, altering, analgesic, API, apnea, articulated, ASP, assigned, Austria, Bank, banking, batch, behavior, Bermuda, biological, broadly, capitalized, captioned, Center, chronic, Citizen, claimed, combining, compassionate, complement, complicated, compounded, compounding, comprising, concentrated, conform, conotoxin, constitutionality, consultation, contemplated, contingency, contracted, CR, creation, creditor, deadline, device, discounting, diversified, diversify, ensuing, entirety, eventually, evidenced, exclusively, exercising, expensed, explicitly, exportation, extinguishment, finalizing, fungal, gaining, GmbH, heard, heparin, IMPD, implanted, incorrectly, incremental, IND, indirect, intolerant, intrathecally, investor, Kabi, Luvox, MAA, mixing, morphine, NARP, neurological, noted, observation, obstructive, occurred, opportunity, opposed, outbreak, oversee, pain, PDUFA, point, practicable, premised, preserve, President, privately, proceeded, psychiatric, readily, ready, recurrent, reducing, refinanced, refinancing, remeasured, renewal, representing, rescission, restate, reviewed, run, safely, sBLA, scalable, schizoaffective, schizophrenia, Situated, solid, strong, struck, suicidal, suit, sulglicotide, summarized, Supreme, surgically, syndicate, syndication, synthesized, systemic, tendered, Topic, toxicity, toxin, traced, traditionally, tranche, transactional, transportation, untendered, updating, upheld, urokinase, User, vascular, Versacloz, VHCA, warranted, wastewater, weighted, workforce, worth, Xavion
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 10.2 Offer Letter
- 10.3 JAZZ Pharmaceuticals PLC 2015 Executive Officer Compensation Arrangements
- 31.1 Certification of CEO Pursuant to Rules 13A-14(A) and 15D-14(A)
- 31.2 Certification of CFO Pursuant to Rules 13A-14(A) and 15D-14(A)
- 32.1 Certifications of CEO and CFO Pursuant to 18 U.s.c. Section 1350
- Download Excel data file
- View Excel data file
Related press release
JAZZ similar filings
Filing view
External links
Exhibit 10.3
2015 Executive Officer Compensation Arrangements
Executive Officer | Base Salary Rate(1) | Target Bonus as % of Annual Base Salary Rate(2) |
Bruce C. Cozadd Chairman and Chief Executive Officer | $875,000 | 100 |
Russell J. Cox Executive Vice President and Chief Operating Officer | $550,000 | 55 |
Suzanne Sawochka Hooper Executive Vice President and General Counsel | $500,000 | 55 |
Matthew P. Young Executive Vice President and Chief Financial Officer | $475,000 | 55 |
Iain McGill Senior Vice President, Jazz Pharmaceuticals Europe and Rest of World | £240,000 | 45 |
Michael P. Miller Senior Vice President, U.S. Commercial | $430,000 | 45 |
Karen Smith, M.D., Ph.D. Global Head of Research & Development and Chief Medical Officer | $475,000 | 45 |
Paul Treacy Senior Vice President, Technical Operations | €250,800 | 45 |
Karen J. Wilson Senior Vice President, Finance and Principal Accounting Officer | $310,000 | 45 |
(1) | 2015 Base salary rates generally effective by March 1, 2015. Dr. Smith’s base salary rate is effective beginning on April 13, 2015, the commencement date of her employment. |
(2) | Target bonus percentage for each officer is based on his or her position and/or responsibility level as provided in Jazz Pharmaceuticals plc’s cash bonus plans. |